Journal Logo

Most Emailed Articles

Targeting the IL-2 inducible kinase in melanoma; a phase 2 study of ibrutinib in systemic treatment-refractory distant metastatic cutaneous melanoma: preclinical rationale, biology, and clinical activity (NCI9922)

Moschos, Stergios J.; Eroglu, Zeynep; Khushalani, Nikhil I.; More

Melanoma Research. 31(2):162-172, April 2021.